Evidence map›Paper›PMID 32693415›Full record

ArticleAmerican journal of perinatology2023

Protecting Breastfeeding during the COVID-19 Pandemic.

Ritu Cheema, Elizabeth Partridge, Laura R Kair, Kara M Kuhn-Riordon, Angelique I Silva, Maria E Bettinelli, Caroline J Chantry, Mark A Underwood, Satyan Lakshminrusimha, Dean Blumberg

Open access · bronzeAbstract read
In one paragraph

Article in American journal of perinatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 88 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Maternal and perinatal COVID-19 - The past, present and the future.Seminars in fetal & neonatal medicine · 2023
    Article
  8. Review
  9. Article
  10. Impact of COVID-19 on breastfeeding intention and behaviour among postpartum women in five countries.Women and birth : journal of the Australian College of Midwives · 2022
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Ritu CheemaDivision of Pediatric Infectious Disease, Department of Pediatrics, University of California, Davis, School of Medicine, Sacramento, California.ORCID 0000-0002-3431-9832
Elizabeth PartridgeDivision of Pediatric Infectious Disease, Department of Pediatrics, University of California, Davis, School of Medicine, Sacramento, California.
Laura R KairDivision of Pediatric Hospital Medicine, Department of Pediatrics, University of California, Davis, School of Medicine, Sacramento, California.
Kara M Kuhn-RiordonDivision of Neonatology, Department of Pediatrics, University of California, Davis, School of Medicine, Sacramento, California.
Angelique I SilvaWomen's Pavilion and Newborn Nursery, UC Davis Medical Center, Sacramento, California.
Maria E BettinelliDepartment of Clinical Science and Community Health, University of Milan, Milan, Italy.
Caroline J ChantryDivision of General Pediatrics, Department of Pediatrics, University of California, Davis, School of Medicine, Sacramento, California.
Mark A UnderwoodDivision of Neonatology, Department of Pediatrics, University of California, Davis, School of Medicine, Sacramento, California.
Satyan LakshminrusimhaDivision of Neonatology, Department of Pediatrics, University of California, Davis, School of Medicine, Sacramento, California.
Dean BlumbergDivision of Pediatric Infectious Disease, Department of Pediatrics, University of California, Davis, School of Medicine, Sacramento, California.
University of California, Davis · USUniversity of California Davis Medical Center · USUniversity of Milan · IT

Funding

UC Davis Clinical and Translational Science CenterUL1TR001860 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KENYON, NICHOLAS J., LYLES, COURTNEY REES · 2016 to 2025
$47.3M
Building Interdisciplinary Research Careers in Womens Health at UC Davis - Administrative SupplementK12HD051958 · NICHD · UNIVERSITY OF CALIFORNIA DAVIS · PI LANE, NANCY E · 2005 to 2023
$9.6M
Building Interdisciplinary Research Careers in Women's Health at UC DavisK12AR084220 · NIAMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Nancy E Lane · 2023 to 2026
$3.0M
NCATS NIH HHS UL1 TR001860NIAMS NIH HHS K12 AR084220NICHD NIH HHS K12 HD051958
6 · The paper itself

Abstract

The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) pandemic has impacted all patient populations including pregnant mothers. There is an incomplete understanding of SARS-CoV-2 pathogenesis and transmission potential at this time and the resultant anxiety has led to variable breastfeeding recommendations for suspected or confirmed mothers with novel coronavirus disease 2019 (COVID-19). Due to the potential concern for transmission of infection from maternal respiratory secretions to the newborn, temporary separation of the maternal-baby dyad, allowing for expressed breast milk to be fed to the infant, was initially recommended but later revised to include breastfeeding by the American Academy of Pediatrics in contrast to international societies, which recommend direct breastfeeding. This separation can have negative health and emotional implications for both mother and baby. Only two publications have reported SARS-CoV-2 in human breast milk but the role of breast milk as a vehicle of transmission of COVID-19 to the newborns still remains unclear and may indeed be providing protective antibodies against SARS-CoV-2 infection even in infected neonates. Other modes of transmission of infection to neonates from infected mothers or any care providers cannot be overemphasized. Symptomatic mothers on hydroxychloroquine can safely breastfeed and no adverse effects were reported in a baby treated with remdesivir in another drug trial. The excretion of sarilumab in human breast milk is unknown at this time. Hence, given the overall safety of breast milk and both short-term and long-term nutritional, immunological, and developmental advantages of breast milk to newborn, breast milk should not be withheld from baby. The setting of maternal care, severity of maternal infection and availability of resources can impact the decision of breastfeeding, the role of shared decision making on breastfeeding between mother and physician needs to be emphasized. We strongly recommend direct breastfeeding with appropriate hygiene precautions unless the maternal or neonatal health condition warrants separation of this dyad. KEY POINTS: · Breastmilk does not appear to play a significant role in transmission of SARS-CoV-2.. · Mother-baby separation has negative health and emotional consequences.. · Mothers with suspected or confirmed COVID-19 can directly breastfeed with appropriate precautions..

Indexed as

COVID-19Pregnancy Complications, InfectiousBreast FeedingChildFemaleHumansInfantInfant, NewbornInfectious Disease Transmission, VerticalMilk, HumanMothersPandemicsPregnancySARS-CoV-2

Identifiers

PMID32693415
PMCPMC7872205
OpenAlexW3044799288

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.